miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.

Advanced cutaneous T-cell lymphoma (CTCL) is resistant to chemotherapy and presents a major area of medical need. In view of the known role of microRNAs (miRNAs) in the regulation of cellular signalling, we aimed to identify the functionally important miRNA species, which regulate apoptosis in CTCL....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Valentina Manfè, Edyta Biskup, Anne Rosbjerg, Maria Kamstrup, Anne Guldhammer Skov, Catharina Margrethe Lerche, Britt Thyssing Lauenborg, Niels Odum, Robert Gniadecki
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/27c2d9fa93da47a5a90672483ae3d169
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:27c2d9fa93da47a5a90672483ae3d169
record_format dspace
spelling oai:doaj.org-article:27c2d9fa93da47a5a90672483ae3d1692021-11-18T07:31:07ZmiR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.1932-620310.1371/journal.pone.0029541https://doaj.org/article/27c2d9fa93da47a5a90672483ae3d1692012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22235305/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Advanced cutaneous T-cell lymphoma (CTCL) is resistant to chemotherapy and presents a major area of medical need. In view of the known role of microRNAs (miRNAs) in the regulation of cellular signalling, we aimed to identify the functionally important miRNA species, which regulate apoptosis in CTCL. Using a recently established model in which apoptosis of CTCL cell lines is induced by Notch-1 inhibition by γ-secretase inhibitors (GSIs), we found that miR-122 was significantly increased in the apoptotic cells. miR-122 up-regulation was not specific for GSI-1 but was also seen during apoptosis induced by chemotherapies including doxorubicin and proteasome blockers (bortezomib, MG132). miR-122 was not expressed in quiescent T-cells, but was detectable in CTCL: in lesional skin in mycosis fungoides and in Sézary cells purified from peripheral blood. In situ hybridization results showed that miR-122 was expressed in the malignant T-cell infiltrate and increased in the advanced stage mycosis fungoides. Surprisingly, miR-122 overexpression decreased the sensitivity to the chemotherapy-induced apoptosis via a signaling circuit involving the activation of Akt and inhibition of p53. We have also shown that induction of miR-122 occurred via p53 and that p53 post-transcriptionally up-regulated miR-122. miR-122 is thus an amplifier of the antiapoptotic Akt/p53 circuit and it is conceivable that a pharmacological intervention in this pathway may provide basis for novel therapies for CTCL.Valentina ManfèEdyta BiskupAnne RosbjergMaria KamstrupAnne Guldhammer SkovCatharina Margrethe LercheBritt Thyssing LauenborgNiels OdumRobert GniadeckiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e29541 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Valentina Manfè
Edyta Biskup
Anne Rosbjerg
Maria Kamstrup
Anne Guldhammer Skov
Catharina Margrethe Lerche
Britt Thyssing Lauenborg
Niels Odum
Robert Gniadecki
miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
description Advanced cutaneous T-cell lymphoma (CTCL) is resistant to chemotherapy and presents a major area of medical need. In view of the known role of microRNAs (miRNAs) in the regulation of cellular signalling, we aimed to identify the functionally important miRNA species, which regulate apoptosis in CTCL. Using a recently established model in which apoptosis of CTCL cell lines is induced by Notch-1 inhibition by γ-secretase inhibitors (GSIs), we found that miR-122 was significantly increased in the apoptotic cells. miR-122 up-regulation was not specific for GSI-1 but was also seen during apoptosis induced by chemotherapies including doxorubicin and proteasome blockers (bortezomib, MG132). miR-122 was not expressed in quiescent T-cells, but was detectable in CTCL: in lesional skin in mycosis fungoides and in Sézary cells purified from peripheral blood. In situ hybridization results showed that miR-122 was expressed in the malignant T-cell infiltrate and increased in the advanced stage mycosis fungoides. Surprisingly, miR-122 overexpression decreased the sensitivity to the chemotherapy-induced apoptosis via a signaling circuit involving the activation of Akt and inhibition of p53. We have also shown that induction of miR-122 occurred via p53 and that p53 post-transcriptionally up-regulated miR-122. miR-122 is thus an amplifier of the antiapoptotic Akt/p53 circuit and it is conceivable that a pharmacological intervention in this pathway may provide basis for novel therapies for CTCL.
format article
author Valentina Manfè
Edyta Biskup
Anne Rosbjerg
Maria Kamstrup
Anne Guldhammer Skov
Catharina Margrethe Lerche
Britt Thyssing Lauenborg
Niels Odum
Robert Gniadecki
author_facet Valentina Manfè
Edyta Biskup
Anne Rosbjerg
Maria Kamstrup
Anne Guldhammer Skov
Catharina Margrethe Lerche
Britt Thyssing Lauenborg
Niels Odum
Robert Gniadecki
author_sort Valentina Manfè
title miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
title_short miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
title_full miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
title_fullStr miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
title_full_unstemmed miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
title_sort mir-122 regulates p53/akt signalling and the chemotherapy-induced apoptosis in cutaneous t-cell lymphoma.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/27c2d9fa93da47a5a90672483ae3d169
work_keys_str_mv AT valentinamanfe mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT edytabiskup mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT annerosbjerg mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT mariakamstrup mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT anneguldhammerskov mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT catharinamargrethelerche mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT brittthyssinglauenborg mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT nielsodum mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
AT robertgniadecki mir122regulatesp53aktsignallingandthechemotherapyinducedapoptosisincutaneoustcelllymphoma
_version_ 1718423336896167936